Compare · LFWD vs STE
LFWD vs STE
Side-by-side comparison of Lifeward Ltd. (LFWD) and STERIS plc (Ireland) (STE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both LFWD and STE operate in Industrial Specialties (Health Care), so they compete in similar markets.
- STE is the larger of the two at $23.05B, about 1101.5x LFWD ($20.9M).
- STE has been more active in the news (16 items in the past 4 weeks vs 11 for LFWD).
- STE has more recent analyst coverage (17 ratings vs 1 for LFWD).
- Company
- Lifeward Ltd.
- STERIS plc (Ireland)
- Price
- $7.88+3.89%
- $236.43-0.47%
- Market cap
- $20.9M
- $23.05B
- 1M return
- +11.29%
- -
- 1Y return
- +5.46%
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- 2014
- News (4w)
- 11
- 16
- Recent ratings
- 1
- 17
STERIS plc (Ireland)
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. This segment offers its products and services to acute care hospitals and other healthcare settings. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The company is based in Dublin, Ireland.
Latest LFWD
- Director Gabay Avraham was granted 13,643 units of Ordinary Shares (SEC Form 4)
- SEC Form 3 filed by new insider Gabay Avraham
- Lifeward Ltd. filed SEC Form 8-K: Leadership Update
- Nano Dimension Appoints Nadav Kidron to Board of Directors to Chair Strategy and Capital Allocation Committee
- SEC Form 10-Q filed by Lifeward Ltd.
- Lifeward Ltd. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits
- Lifeward Reports Strong Second Quarter 2026 Financial Results as Commercial Execution Drives Growth
- SEC Form EFFECT filed by Lifeward Ltd.
- Lifeward to Report Second Quarter 2026 Financial Results on August 14, 2026
- Lifeward Launches Pilot Program with Ottobock Care to Expand National Access to ReWalk® Personal Exoskeleton
Latest STE
- SEC Form 144 filed by STERIS plc (Ireland)
- SEC Form 4 filed by Director Shapiro Louis
- Director Sohi Mohsen exercised 4,058 units of Ordinary Shares at a strike of $86.23 and sold $956,795 worth of Ordinary Shares (4,058 units at $235.78) (SEC Form 4)
- SEC Form 4 filed by Director Shah Nirav R
- SEC Form 4 filed by Director Martin Paul Edward
- SEC Form 4 filed by Director Boulud Pierre
- SEC Form 4 filed by Director Feldmann Cynthia L
- SEC Form 4 filed by Director Holland Christopher S
- SEC Form 4 filed by Director Alegria Esther M.
- SEC Form 144 filed by STERIS plc (Ireland)